Default object view. Click to create a custom template, Node ID: 76111, Object ID: 47300

Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a p...

Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial

No relation

Yes

No relation

No

15/07/2014 7:04 pm